The counter has had a total traded volume of 21766 shares so far with a value of Rs 2.03 crore on the NSE. It traded at a price-to-earnings multiple of 25.54 and a price-to-book ratio of 3.36.
A higher price-to-earnings ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and reflects the price investors are willing to pay even for no growth in the business.
The scrip declined 3.44 per cent during the past one year, while the 30-share index advanced 50.39 per cent during the same period.
Lupin Ltd. belongs to the Pharma – Indian industry.
Promotor/FII Holding
Promoters held 46.54 per cent stake in the company as of 30-Sep-2021, while foreign investors and domestic institutional investors ownership stood at 15.66 per cent and 13.33 per cent, respectively.
Key Financials
The firm reported consolidated net sales of Rs 4298.02 crore for the quarter ended 30-Jun-2021, up 11.89 per cent from the previous quarter’s Rs 3841.32 crore and up 20.35 per cent from the year-ago quarter’s Rs 3571.14 crore.
Profit for the latest quarter stood at Rs 542.46 crore, up 407.45 per cent from the same quarter a year ago.
